Recent Securities Litigations

Homology Medicines Inc. Common Stock (NASDAQ: FIXX)

Company Name:Homology Medicines Inc. Common Stock
Stock Symbol:NASDAQ: FIXX
Class Period Start:06/10/2019
Class Period End (inclusive):02/18/2022

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and compliance policies. Specifically, the Complaint alleges Defendants made false and/or misleading statements and/or failed to disclose that: (i) the Company had overstated HMI-102's efficacy and risk mitigation; (ii) accordingly, it was unlikely that the Company would be able to commercialize HMI-102 in its present form; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.